SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing significant upward momentum and heightened investor interest driven by a combination of strong institutional buying, a potential short squeeze setup, and anticipation ahead of the upcoming earnings report. The community is actively discussing the stock's high short interest and limited share availability, which many hope will trigger a sustained rally.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is surging following reports that the company is preparing a massive bid to acquire eBay, with retail investors buzzing over the potential for a transformative marketplace merger. While the community is actively debating the feasibility and financial structure of a deal of this scale, many traders are positioning themselves for potential volatility and short squeeze activity heading into the next session.

Federal National Mortgage Association is a government-sponsored company, which engages in the provision of liquidity for purchases of homes and financing of multifamily rental housing and refinancing existing mortgages. It operates through the Single-Family and Multifamily segments. The Single-Family segment offers liquidity to the mortgage market and increases the availability and affordability of housing for single families. The Multifamily segment includes guaranty fees on mortgages and on multifamily mortgage loans. The company was founded in 1938 and is headquartered in Washington, DC.

Federal National Mortgage Association

Fannie Mae shares are surging following high-profile endorsements from prominent investors who have characterized the stock as significantly undervalued, sparking heavy speculation about a potential path toward privatization and the end of conservatorship. The community remains divided between intense bullish optimism for a historic exit strategy and skepticism from those concerned that recent volatility may be a classic pump-and-dump scheme driven by retail FOMO.

eBay, Inc. is a commerce company, whose platforms include an online marketplace and its localized counterparts, including off-platform businesses in South Korea, Japan, and Turkey, as well as eBay’s suite of mobile apps. It offers a platform for various product categories, including parts and accessories, collectibles, fashion, electronics, and home & garden. eBay generates revenue mainly through fees from sales, payment processing, and advertising. The company was founded by Pierre Morad Omidyar in September 1995 and is headquartered in San Jose, CA.

EBay Inc.

eBay Inc

eBay shares are experiencing significant volatility following a WSJ report that GameStop is building a stake and planning a multibillion-dollar takeover offer. While retail traders are actively debating the feasibility of the acquisition given the valuation gap, the news has ignited widespread speculation and heavy trading activity.

Melania memes are digital collectibles intended to function as an expression of support for and engagement with the values embodied by the symbol MELANIA

Melania Trump

The MELANIA crypto token continues to generate intense controversy within the community, with many investors labeling it a failed project following a significant loss in value since its launch. Discussion is dominated by heated debates over the Trump family's financial influence and skepticism regarding the utility or long-term legitimacy of politically-linked meme coins.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is trending following an End-of-Phase 2 meeting with the FDA, which established a pivotal Phase 3 registration path for CAD-1005 to treat heparin-induced thrombocytopenia. Community members are actively debating the company's long-term pipeline potential and clinical milestones against concerns regarding stock promotion, bot activity, and the recurring need for capital raises.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is currently a major focus for traders due to heavy short interest and speculation regarding a potential leadership change or privatization, with community sentiment split between frustration over stagnant price action and conviction in a long-term turnaround. Investors are closely monitoring the board's lack of CEO progress while debating whether the brand's international expansion and current valuation present a deep value opportunity.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending following a NOAA determination of full compliance for its consolidated deep-seabed mining application, a key regulatory milestone that has sparked intense debate among investors regarding the company's path to commercial permit approval by 2027. Community discussion is sharply divided between bulls highlighting the company's decade of accumulated data and strategic value in the critical minerals supply chain, and skeptics focused on potential permitting delays, executive stock sales, and the lack of established commercial production.

ProShares Trust II - ProShares Ultra Silver 2x Shares

ProShares Ultra Silver

ProShares Ultra Silver is trending as traders closely monitor extreme volatility, potential COMEX delivery squeezes, and the impact of geopolitical tension on silver's supply-demand imbalance. Community discussion remains heavily polarized between bulls anticipating a massive short squeeze due to depleted physical vaults and bears warning of significant time-decay risks associated with leveraged ETFs.

WorldFinancial

World Liberty Financial (WLFI) is currently trending as investors debate a proposed governance plan to implement a multi-year token lockup, vesting schedule, and potential burn of billions of tokens. While some community members view these measures as a bullish supply shock and a necessary step to stabilize the ecosystem, others express significant skepticism, citing ongoing legal challenges, regulatory scrutiny into foreign investment deals, and concerns over the project's long-term transparency.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Mirum Pharmaceuticals to Host Investor Call to Share Topline Results from the VISTAS Study of Volixibat in Patients with Primary Sclerosing Cholangitis on May 4, 2026

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced that it will host an investor call on Monday, May 4, 2026 at 8:30 a.m. ET/5:30 a.m. PT to share topline...

Pictet Asset Management Holding SA Purchases 35,997 Shares of Mirum Pharmaceuticals, Inc. $MIRM

Pictet Asset Management Holding SA boosted its position in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) by 6.7% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 577,274 shares of the company's stock after purcha...

Mirum Pharmaceuticals to Announce First Quarter 2026 Financial Results and Host Conference Call on May 6, 2026

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced that it will report first quarter 2026 financial results on May 6, 2026. Mirum will also host a conference...

Mirum Pharmaceuticals, Inc. (MIRM) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Mirum Pharmaceuticals (MIRM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target Raised to $130.00 at Stifel Nicolaus

Stifel Nicolaus boosted their target price on shares of Mirum Pharmaceuticals from $125.00 to $130.00 and gave the company a "buy" rating in a report on Wednesday...

Biogen Inc. (BIIB) Tops Q1 Earnings and Revenue Estimates

Biogen (BIIB) delivered earnings and revenue surprises of +20.87% and +10.12%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Mirum Pharmaceuticals (MIRM) Expected to Announce Quarterly Earnings on Wednesday

Mirum Pharmaceuticals (NASDAQ:MIRM) will be releasing its Q1 2026 earnings after the market closes on Wednesday, May 6. (View Earnings Report at...

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Given Average Rating of "Moderate Buy" by Analysts

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Get Free Report) has received a consensus rating of "Moderate Buy" from the fourteen brokerages that are currently covering the company, Marketbeat.com reports. One analyst has rated the stock with a sell rating, twelve have given a buy rating and one ha...

Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target Raised to $112.00 at Robert W. Baird

Robert W. Baird raised their target price on shares of Mirum Pharmaceuticals from $95.00 to $112.00 and gave the stock an "outperform" rating in a research report on Tuesday...

Mirum Pharmaceuticals Announces Primary Endpoint Met in Phase 2b Portion of the AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta Virus

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced the primary endpoint was met in the Phase 2b portion of the AZURE-1 study evaluating brelovitug, an...

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its products include Maralixibat and Volixibat. The company was founded by Niall O'Donnel, Michael Grey and Christopher Peetz in May 2018 and is headquartered in Foster City, CA.

MIRM
Mirum Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest MIRM News

MIRMMirum Pharmaceuticals Inc